Karl Staser - Concepedia

Author

Karl Staser

Indiana University – Purdue University Indianapolis

Also Known As

Angus, Steven P, K Staser, K. Staser, Karl Staser, Karl W Staser, Karl W. Staser, Karl William Staser, Staser, Karl W.

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Washington University in St. Louis Indiana University School of Medicine Massachusetts General Hospital Harvard University

About

Karl Staser is an author at Indiana University – Purdue University Indianapolis specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.1K
2	Cell Biology	6	6	286
3	Health Sciences	3	3	465
4	Cellular Physiology	3	3	150
5	Blood Transplantation	1	1	57

Karl Staser

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies Matthew Cooper, Jaebok Choi, Karl Staser, Leukemia Cell TherapyHematologyImmunologyCell Replacement TherapyImmunotherapy	2018	381
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial Kent A. Robertson, Grzegorz Nalepa, Feng‐Chun Yang, The Lancet Oncology Neuro-oncologySurgical PathologyPathologyNeurofibromatosis Type 1Phase 2	2012	226
Erk1 Positively Regulates Osteoclast Differentiation and Bone Resorptive Activity Yongzheng He, Karl Staser, Steven D. Rhodes, PLoS ONE	2011	125
A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation Jeffrey R. Gehlhausen, Su-Jung Park, Ann E. Hickox, Human Molecular Genetics	2014	107
A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease Mark A. Schroeder, H. Jean Khoury, Madan Jagasia, Blood Advances	2020	94
Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease Jaebok Choi, Matthew Cooper, Karl Staser, Leukemia InflammationCytokineGraft-versus-host DiseaseAutoimmune DiseaseImmunosuppressive Therapy	2018	88
A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity Miriam Kim, Reyka G. Jayasinghe, Jessica M. Devenport, Nature Communications T Cell TherapyT-regulatory CellImmunologyImmunologic MechanismImmunotherapy	2022	86
OMIP‐042: 21‐color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral blood Karl Staser, William Eades, Jaebok Choi, Cytometry Part A Type 17ImmunohematologyCell TherapyImmunodeficienciesImmunology	2017	57
Identification of molecular compartments and genetic circuitry in the developing mammalian kidney Jing Yu, M. Todd Valerius, Mary Duah, Development GeneticsMolecular GeneticsNephrologyOrgan DevelopmentGene Expression Profiling	2012	56
Hyperactive Transforming Growth Factor-β1 Signaling Potentiates Skeletal Defects in a Neurofibromatosis Type 1 Mouse Model Steven D. Rhodes, Xiaohua Wu, Yongzheng He, Journal of Bone and Mineral Research	2013	53

Page 1